Targeted chemotherapy or placebo to treat patient with lung cancer that has been completely removed by surgery
Can targeted chemotherapy (Erlotinib) stop the growth of tumor cells by blocking some of the enzymes needed for cell growth?
ALK Gene Rearrangement EGFR Exon 19 Deletion Mutation EGFR NP_005219.2:p.L858R Stage IB Non-Small Cell Lung Carcinoma AJCC v7 Stage II Non-Small Cell Lung Cancer AJCC v7 Stage IIA Non-Small Cell Lung Carcinoma AJCC v7 Stage IIB Non-Small Cell Lung Carcinoma AJCC v7 Stage IIIA Non-Small Cell Lung Cancer AJCC v7 Carcinoma Lung Neoplasms Carcinoma, Non-Small-Cell Lung Erlotinib Hydrochloride Clinical Observation Laboratory Biomarker Analysis
Lead Scientists at UC Health
- Lyudmila A. Bazhenova (ucsd)
Dr. Bazhenova’s clinical practice and research concentrate on lung cancer, particularly as this relates to females and non-smokers. She actively participates in cooperative group trials, and takes an active role in designing and implementing clinical investigations, including phase II studies and correlative science projects with several UCSD investigators.
- Jonathan W. Riess (ucdavis)
Authored (or co-authored) 30 research publications
- accepting new patients
- Start Date
- National Cancer Institute (NCI)
- Phase 3
- Study Type
- Last Updated